Invitation to Submit Proposals under Framework Agreement(s) 2023/436 - Central Nervous System Medications, 2023/491 - Oncological and Immunomodulatory Medications, 2023/492 - Anti-infective Medications, 2024/898 - Analgesic, Antipyretic, and Antidepressant Medications, 2024/961 - Miscellaneous Medications, 2025/1303 - Miscellaneous Medications, 2025/1367 - Digestive System Medications, 2025/1428 - Antipsychotic, Anesthetic, and Muscle Relaxant Medications, 2025/1

This tender is an invitation to submit proposals under several existing framework agreements for the supply of various categories of medications. The framework agreements cover a broad spectrum of pharmaceutical products, including those for the central nervous system, oncology, immunology, anti-infectives, pain management (analgesics and antipyretics), antidepressants, digestive system treatments, and medications for psychiatric conditions (antipsychotics), anesthesia, and muscle relaxation. The reference '2025/1' at the end suggests there might be an additional, incomplete framework agreement reference or a continuation of the list. The purpose is to solicit bids from suppliers who are party to these framework agreements to fulfill specific orders or requirements for these diverse drug categories. The process aims to streamline the procurement of essential medicines through pre-established contractual terms.

This is a supplies contract in the health and medical services and information and communication technology sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 12,461.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.